What is the ticker symbol for Kronos Bio?

Kronos Bio trades under the ticker KRON on NASDAQ.

What sector does Kronos Bio operate in?

Kronos Bio is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze KRON in a portfolio?

PortView shows KRON's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Kronos Bio (KRON) Stock Analysis

NASDAQHealthcareBiotechnology

$0.88+1.49%

1-year price historyRange $0.67 – $1.50

52-week range$0.88

$0.65$1.46

What Kronos Bio does

Kronos Bio, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to the identification and advancement of innovative therapies for cancer. Its therapeutic strategy centers on modulating dysregulated transcription factors and the intricate transcriptional regulatory networks that fuel oncogenic activity. The company's primary investigational drug, entospletinib (ENTO), is an orally administered, selective inhibitor of spleen tyrosine kinase (SYK), designed for patients with acute myeloid leukemia. A registrational Phase 3 clinical trial is slated to evaluate ENTO in combination with induction chemotherapy for acute myeloid leukemia patients who possess NPM1 mutations. Furthermore, Kronos Bio is progressing KB-0742, an orally bioavailable cyclin dependent kinase 9 (CDK9) inhibitor, which is currently undergoing Phase 1/2 clinical assessment for the treatment of MYC-amplified solid tumors. Established in 2017, the company maintains its headquarters in San Mateo, California.

Key metrics

Market cap

$53.65M

P/E (TTM)

-0.82

EPS (TTM)

$-1.07

Beta

1.64

Dividend yield

0.00%

Revenue / share

$0.16

50-day avg

$0.80

200-day avg

$0.90

52-week high

$1.46

52-week low

$0.65

CEO

Deborah A. Knobelman

ETFs linked to KRON

Broad-market and Healthcare sector ETFs an investor holding Kronos Bio is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how KRON fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze KRON in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Kronos Bio?: Kronos Bio trades under the ticker KRON on NASDAQ.
Which exchange is KRON listed on?: KRON is listed on NASDAQ.
What sector does Kronos Bio operate in?: Kronos Bio is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze KRON in a portfolio?: PortView shows KRON's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.